+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Cell Banking Outsourcing Market by Service Type, Cell Type, Application, End User - Global Forecast to 2030- Product Image
Cell Banking Outsourcing Market by Service Type, Cell Type, Application, End User - Global Forecast to 2030- Product Image
Sale

Cell Banking Outsourcing Market by Service Type, Cell Type, Application, End User - Global Forecast to 2030

  • PDF Icon

    Report

  • 199 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 6011245
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Cell banking outsourcing is rapidly becoming a strategic cornerstone for leaders across the biopharmaceutical sector, driven by the growing importance of operational efficiency, regulatory compliance, and accelerated product development in a highly competitive global landscape. Senior decision-makers are under pressure to align their organizations with partners offering specialized capabilities and flexible service models, ensuring projects advance with agility and strong quality assurance.

Market Snapshot: Cell Banking Outsourcing Market Growth

The Cell Banking Outsourcing Market grew from USD 14.57 billion in 2024 to USD 16.96 billion in 2025. It is projected to maintain robust momentum at a CAGR of 15.68%, reaching USD 34.93 billion by 2030. Expansion is supported by rising demand for personalized therapies, increased manufacturing complexity, and mounting regulatory scrutiny, placing emphasis on scalable external partnerships.

Scope & Segmentation of the Market

  • Service Types: Custom and standard cell expansion, cold chain logistics, inventory management, genetic and safety testing, viability evaluation, and secure storage offerings.
  • Cell Types: Mammalian cell lines (such as CHO, hybridoma, NS0), microbial hosts (E. coli, yeast), and advanced stem cell categories including hematopoietic, mesenchymal, and induced pluripotent cells.
  • Applications: Production for biopharmaceuticals, gene therapies (AAV or lentiviral systems), regenerative medicine (cell therapy, tissue engineering), and recombinant or viral vaccine operations.
  • End Users: Academic institutes, both large and small biotechnology companies, clinical and preclinical contract research organizations, and pharmaceutical manufacturers.
  • Regional Markets: Americas (U.S., Canada, Mexico, Brazil, Argentina); Europe, Middle East & Africa (including the UK, Germany, France, Russia, UAE, South Africa, and others); Asia-Pacific (China, India, Japan, Australia, South Korea, and additional key Asian economies).
  • Key Technologies: Modular and integrated campus models, digital quality management platforms, high-throughput cryopreservation, robotics-enabled cell handling, and cloud-based analytics further elevate industry standards and process reproducibility.
  • Leading Providers: Prominent market participants include Lonza Group AG, Thermo Fisher Scientific Inc., Merck KGaA, Cytiva Uppsala AB, Fujifilm Diosynth Biotechnologies UK Limited, WuXi AppTec Co., Ltd., AGC Biologics Inc., Catalent, Inc., Cobra Biologics Group Limited, and Selexis SA.

Key Takeaways for Senior Decision-Makers

  • Outsourcing cell banking functions allows organizations to access advanced expertise and infrastructure that many internal teams cannot maintain at scale.
  • End-to-end service integration, including expansion, testing, and storage, creates greater process continuity and operational agility.
  • Advanced automation and cloud-based quality management solutions are streamlining workflows, improving reproducibility, and reducing manual intervention risks.
  • Service providers are adapting by offering modular capacity and flexible service packages, enabling sponsors to scale operations efficiently during clinical and commercial phases.
  • Strategic partnerships across technology, academia, and service sectors are accelerating workflow innovation, enhancing traceability, and supporting the needs of next-generation therapies.
  • Regional differences influence service delivery models, with mature markets prioritizing digital systems, and emerging regions investing in foundational biotechnology capacities.

Tariff Impact: Responding to Shifting Supply Chain Pressures

The 2025 United States tariffs have heightened cost pressures on service providers, leading to recalibrated sourcing and procurement strategies. By diversifying supplier bases and localizing critical components, organizations are mitigating risk exposure while maintaining resilient supply chains. Flexible pricing models and domestic manufacturing initiatives have emerged in response to shifting import duties, allowing sponsors to buffer costs and secure continuity.

Methodology & Data Sources

This research integrates direct interviews with senior biopharmaceutical executives, comprehensive reviews of scientific and regulatory materials, and competitive intelligence including company disclosures and patent filings. All findings rely on triangulation of insights and expert panel validation to ensure analytical rigor and actionable intelligence.

Why This Report Matters

  • Offers a detailed view of key cell banking outsourcing trends supporting strategic planning and risk mitigation.
  • Supports procurement and partnership decisions by mapping top providers, service models, and technology adoption curves.
  • Provides critical segmentation and regional intelligence for aligning investments with evolving therapeutic, regulatory, and operational requirements.

Conclusion

Cell banking outsourcing is reshaping how biopharmaceutical leaders address operational complexity and innovation. Executives leveraging digital transformation, strategic partnerships, and supply chain agility will be best positioned to capture emerging opportunities in next-generation therapy development.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Cell Banking Outsourcing Market, by Service Type
8.1. Introduction
8.2. Cell Expansion Services
8.2.1. Custom Cell Expansion
8.2.2. Standard Cell Expansion
8.3. Logistics Services
8.3.1. Cold Chain Logistics
8.3.2. Inventory Management
8.4. Quality Control Testing
8.4.1. Genetic Characterization
8.4.2. Safety Testing
8.4.3. Viability Testing
8.5. Storage Services
9. Cell Banking Outsourcing Market, by Cell Type
9.1. Introduction
9.2. Mammalian Cells
9.2.1. CHO Cells
9.2.2. Hybridoma Cells
9.2.3. NS0 Cells
9.3. Microbial Cells
9.3.1. E Coli Cells
9.3.2. Yeast Cells
9.4. Stem Cells
9.4.1. Hematopoietic Stem Cells
9.4.2. Induced Pluripotent Stem Cells
9.4.3. Mesenchymal Stem Cells
10. Cell Banking Outsourcing Market, by Application
10.1. Introduction
10.2. Biopharmaceutical Manufacturing
10.2.1. MAb Production
10.2.2. Protein Therapeutics
10.3. Gene Therapy
10.3.1. AAV-Based Therapies
10.3.2. Lentiviral Therapies
10.4. Regenerative Medicine
10.4.1. Cell Therapy
10.4.2. Tissue Engineering
10.5. Vaccine Production
10.5.1. Recombinant Vaccines
10.5.2. Viral Vaccines
11. Cell Banking Outsourcing Market, by End User
11.1. Introduction
11.2. Academic Institutes
11.3. Biotechnology Companies
11.3.1. Large Biotech
11.3.2. Small Biotech
11.4. Contract Research Organizations
11.4.1. Clinical CROs
11.4.2. Preclinical CROs
11.5. Pharmaceutical Companies
12. Americas Cell Banking Outsourcing Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Cell Banking Outsourcing Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Cell Banking Outsourcing Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Lonza Group AG
15.3.2. Thermo Fisher Scientific Inc.
15.3.3. Merck KGaA
15.3.4. Cytiva Uppsala AB
15.3.5. Fujifilm Diosynth Biotechnologies UK Limited
15.3.6. WuXi AppTec Co., Ltd.
15.3.7. AGC Biologics Inc.
15.3.8. Catalent, Inc.
15.3.9. Cobra Biologics Group Limited
15.3.10. Selexis SA
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. CELL BANKING OUTSOURCING MARKET MULTI-CURRENCY
FIGURE 2. CELL BANKING OUTSOURCING MARKET MULTI-LANGUAGE
FIGURE 3. CELL BANKING OUTSOURCING MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY CELL TYPE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY CELL TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS CELL BANKING OUTSOURCING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS CELL BANKING OUTSOURCING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES CELL BANKING OUTSOURCING MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES CELL BANKING OUTSOURCING MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA CELL BANKING OUTSOURCING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA CELL BANKING OUTSOURCING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC CELL BANKING OUTSOURCING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC CELL BANKING OUTSOURCING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. CELL BANKING OUTSOURCING MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. CELL BANKING OUTSOURCING MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. CELL BANKING OUTSOURCING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY CELL EXPANSION SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY CUSTOM CELL EXPANSION, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY STANDARD CELL EXPANSION, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY CELL EXPANSION SERVICES, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY LOGISTICS SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY COLD CHAIN LOGISTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY INVENTORY MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY LOGISTICS SERVICES, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY QUALITY CONTROL TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY GENETIC CHARACTERIZATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY SAFETY TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY VIABILITY TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY QUALITY CONTROL TESTING, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY STORAGE SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY MAMMALIAN CELLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY CHO CELLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY HYBRIDOMA CELLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY NS0 CELLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY MAMMALIAN CELLS, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY MICROBIAL CELLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY E COLI CELLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY YEAST CELLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY MICROBIAL CELLS, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY STEM CELLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY HEMATOPOIETIC STEM CELLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY INDUCED PLURIPOTENT STEM CELLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY MESENCHYMAL STEM CELLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY STEM CELLS, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY BIOPHARMACEUTICAL MANUFACTURING, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY MAB PRODUCTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY PROTEIN THERAPEUTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY BIOPHARMACEUTICAL MANUFACTURING, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY GENE THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY AAV-BASED THERAPIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY LENTIVIRAL THERAPIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY GENE THERAPY, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY REGENERATIVE MEDICINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY CELL THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY TISSUE ENGINEERING, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY REGENERATIVE MEDICINE, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY VACCINE PRODUCTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY RECOMBINANT VACCINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY VIRAL VACCINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY VACCINE PRODUCTION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY ACADEMIC INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY LARGE BIOTECH, BY REGION, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY SMALL BIOTECH, BY REGION, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 60. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY CLINICAL CROS, BY REGION, 2018-2030 (USD MILLION)
TABLE 61. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY PRECLINICAL CROS, BY REGION, 2018-2030 (USD MILLION)
TABLE 62. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 63. GLOBAL CELL BANKING OUTSOURCING MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 64. AMERICAS CELL BANKING OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 65. AMERICAS CELL BANKING OUTSOURCING MARKET SIZE, BY CELL EXPANSION SERVICES, 2018-2030 (USD MILLION)
TABLE 66. AMERICAS CELL BANKING OUTSOURCING MARKET SIZE, BY LOGISTICS SERVICES, 2018-2030 (USD MILLION)
TABLE 67. AMERICAS CELL BANKING OUTSOURCING MARKET SIZE, BY QUALITY CONTROL TESTING, 2018-2030 (USD MILLION)
TABLE 68. AMERICAS CELL BANKING OUTSOURCING MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 69. AMERICAS CELL BANKING OUTSOURCING MARKET SIZE, BY MAMMALIAN CELLS, 2018-2030 (USD MILLION)
TABLE 70. AMERICAS CELL BANKING OUTSOURCING MARKET SIZE, BY MICROBIAL CELLS, 2018-2030 (USD MILLION)
TABLE 71. AMERICAS CELL BANKING OUTSOURCING MARKET SIZE, BY STEM CELLS, 2018-2030 (USD MILLION)
TABLE 72. AMERICAS CELL BANKING OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 73. AMERICAS CELL BANKING OUTSOURCING MARKET SIZE, BY BIOPHARMACEUTICAL MANUFACTURING, 2018-2030 (USD MILLION)
TABLE 74. AMERICAS CELL BANKING OUTSOURCING MARKET SIZE, BY GENE THERAPY, 2018-2030 (USD MILLION)
TABLE 75. AMERICAS CELL BANKING OUTSOURCING MARKET SIZE, BY REGENERATIVE MEDICINE, 2018-2030 (USD MILLION)
TABLE 76. AMERICAS CELL BANKING OUTSOURCING MARKET SIZE, BY VACCINE PRODUCTION, 2018-2030 (USD MILLION)
TABLE 77. AMERICAS CELL BANKING OUTSOURCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 78. AMERICAS CELL BANKING OUTSOURCING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 79. AMERICAS CELL BANKING OUTSOURCING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 80. AMERICAS CELL BANKING OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 81. UNITED STATES CELL BANKING OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 82. UNITED STATES CELL BANKING OUTSOURCING MARKET SIZE, BY CELL EXPANSION SERVICES, 2018-2030 (USD MILLION)
TABLE 83. UNITED STATES CELL BANKING OUTSOURCING MARKET SIZE, BY LOGISTICS SERVICES, 2018-2030 (USD MILLION)
TABLE 84. UNITED STATES CELL BANKING OUTSOURCING MARKET SIZE, BY QUALITY CONTROL TESTING, 2018-2030 (USD MILLION)
TABLE 85. UNITED STATES CELL BANKING OUTSOURCING MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 86. UNITED STATES CELL BANKING OUTSOURCING MARKET SIZE, BY MAMMALIAN CELLS, 2018-2030 (USD MILLION)
TABLE 87. UNITED STATES CELL BANKING OUTSOURCING MARKET SIZE, BY MICROBIAL CELLS, 2018-2030 (USD MILLION)
TABLE 88. UNITED STATES CELL BANKING OUTSOURCING MARKET SIZE, BY STEM CELLS, 2018-2030 (USD MILLION)
TABLE 89. UNITED STATES CELL BANKING OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 90. UNITED STATES CELL BANKING OUTSOURCING MARKET SIZE, BY BIOPHARMACEUTICAL MANUFACTURING, 2018-2030 (USD MILLION)
TABLE 91. UNITED STATES CELL BANKING OUTSOURCING MARKET SIZE, BY GENE THERAPY, 2018-2030 (USD MILLION)
TABLE 92. UNITED STATES CELL BANKING OUTSOURCING MARKET SIZE, BY REGENERATIVE MEDICINE, 2018-2030 (USD MILLION)
TABLE 93. UNITED STATES CELL BANKING OUTSOURCING MARKET SIZE, BY VACCINE PRODUCTION, 2018-2030 (USD MILLION)
TABLE 94. UNITED STATES CELL BANKING OUTSOURCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 95. UNITED STATES CELL BANKING OUTSOURCING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 96. UNITED STATES CELL BANKING OUTSOURCING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 97. UNITED STATES CELL BANKING OUTSOURCING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 98. CANADA CELL BANKING OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 99. CANADA CELL BANKING OUTSOURCING MARKET SIZE, BY CELL EXPANSION SERVICES, 2018-2030 (USD MILLION)
TABLE 100. CANADA CELL BANKING OUTSOURCING MARKET SIZE, BY LOGISTICS SERVICES, 2018-2030 (USD MILLION)
TABLE 101. CANADA CELL BANKING OUTSOURCING MARKET SIZE, BY QUALITY CONTROL TESTING, 2018-2030 (USD MILLION)
TABLE 102. CANADA CELL BANKING OUTSOURCING MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 103. CANADA CELL BANKING OUTSOURCING MARKET SIZE, BY MAMMALIAN CELLS, 2018-2030 (USD MILLION)
TABLE 104. CANADA CELL BANKING OUTSOURCING MARKET SIZE, BY MICROBIAL CELLS, 2018-2030 (USD MILLION)
TABLE 105. CANADA CELL BANKING OUTSOURCING MARKET SIZE, BY STEM CELLS, 2018-2030 (USD MILLION)
TABLE 106. CANADA CELL BANKING OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 107. CANADA CELL BANKING OUTSOURCING MARKET SIZE, BY BIOPHARMACEUTICAL MANUFACTURING, 2018-2030 (USD MILLION)
TABLE 108. CANADA CELL BANKING OUTSOURCING MARKET SIZE, BY GENE THERAPY, 2018-2030 (USD MILLION)
TABLE 109. CANADA CELL BANKING OUTSOURCING MARKET SIZE, BY REGENERATIVE MEDICINE, 2018-2030 (USD MILLION)
TABLE 110. CANADA CELL BANKING OUTSOURCING MARKET SIZE, BY VACCINE PRODUCTION, 2018-2030 (USD MILLION)
TABLE 111. CANADA CELL BANKING OUTSOURCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 112. CANADA CELL BANKING OUTSOURCING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 113. CANADA CELL BANKING OUTSOURCING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 114. MEXICO CELL BANKING OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 115. MEXICO CELL BANKING OUTSOURCING MARKET SIZE, BY CELL EXPANSION SERVICES, 2018-2030 (USD MILLION)
TABLE 116. MEXICO CELL BANKING OUTSOURCING MARKET SIZE, BY LOGISTICS SERVICES, 2018-2030 (USD MILLION)
TABLE 117. MEXICO CELL BANKING OUTSOURCING MARKET SIZE, BY QUALITY CONTROL TESTING, 2018-2030 (USD MILLION)
TABLE 118. MEXICO CELL BANKING OUTSOURCING MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 119. MEXICO CELL BANKING OUTSOURCING MARKET SIZE, BY MAMMALIAN CELLS, 2018-2030 (USD MILLION)
TABLE 120. MEXICO CELL BANKING OUTSOURCING MARKET SIZE, BY MICROBIAL CELLS, 2018-2030 (USD MILLION)
TABLE 121. MEXICO CELL BANKING OUTSOURCING MARKET SIZE, BY STEM CELLS, 2018-2030 (USD MILLION)
TABLE 122. MEXICO CELL BANKING OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 123. MEXICO CELL BANKING OUTSOURCING MARKET SIZE, BY BIOPHARMACEUTICAL MANUFACTURING, 2018-2030 (USD MILLION)
TABLE 124. MEXICO CELL BANKING OUTSOURCING MARKET SIZE, BY GENE THERAPY, 2018-2030 (USD MILLION)
TABLE 125. MEXICO CELL BANKING OUTSOURCING MARKET SIZE, BY REGENERATIVE MEDICINE, 2018-2030 (USD MILLION)
TABLE 126. MEXICO CELL BANKING OUTSOURCING MARKET SIZE, BY VACCINE PRODUCTION, 2018-2030 (USD MILLION)
TABLE 127. MEXICO CELL BANKING OUTSOURCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 128. MEXICO CELL BANKING OUTSOURCING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 129. MEXICO CELL BANKING OUTSOURCING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 130. BRAZIL CELL BANKING OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 131. BRAZIL CELL BANKING OUTSOURCING MARKET SIZE, BY CELL EXPANSION SERVICES, 2018-2030 (USD MILLION)
TABLE 132. BRAZIL CELL BANKING OUTSOURCING MARKET SIZE, BY LOGISTICS SERVICES, 2018-2030 (USD MILLION)
TABLE 133. BRAZIL CELL BANKING OUTSOURCING MARKET SIZE, BY QUALITY CONTROL TESTING, 2018-2030 (USD MILLION)
TABLE 134. BRAZIL CELL BANKING OUTSOURCING MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 135. BRAZIL CELL BANKING OUTSOURCING MARKET SIZE, BY MAMMALIAN CELLS, 2018-2030 (USD MILLION)
TABLE 136. BRAZIL CELL BANKING OUTSOURCING MARKET SIZE, BY MICROBIAL CELLS, 2018-2030 (USD MILLION)
TABLE 137. BRAZIL CELL BANKING OUTSOURCING MARKET SIZE, BY STEM CELLS, 2018-2030 (USD MILLION)
TABLE 138. BRAZIL CELL BANKING OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 139. BRAZIL CELL BANKING OUTSOURCING MARKET SIZE, BY BIOPHARMACEUTICAL MANUFACTURING, 2018-2030 (USD MILLION)
TABLE 140. BRAZIL CELL BANKING OUTSOURCING MARKET SIZE, BY GENE THERAPY, 2018-2030 (USD MILLION)
TABLE 141. BRAZIL CELL BANKING OUTSOURCING MARKET SIZE, BY REGENERATIVE MEDICINE, 2018-2030 (USD MILLION)
TABLE 142. BRAZIL CELL BANKING OUTSOURCING MARKET SIZE, BY VACCINE PRODUCTION, 2018-2030 (USD MILLION)
TABLE 143. BRAZIL CELL BANKING OUTSOURCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 144. BRAZIL CELL BANKING OUTSOURCING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 145. BRAZIL CELL BANKING OUTSOURCING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 146. ARGENTINA CELL BANKING OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 147. ARGENTINA CELL BANKING OUTSOURCING MARKET SIZE, BY CELL EXPANSION SERVICES, 2018-2030 (USD MILLION)
TABLE 148. ARGENTINA CELL BANKING OUTSOURCING MARKET SIZE, BY LOGISTICS SERVICES, 2018-2030 (USD MILLION)
TABLE 149. ARGENTINA CELL BANKING OUTSOURCING MARKET SIZE, BY QUALITY CONTROL TESTING, 2018-2030 (USD MILLION)
TABLE 150. ARGENTINA CELL BANKING OUTSOURCING MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 151. ARGENTINA CELL BANKING OUTSOURCING MARKET SIZE, BY MAMMALIAN CELLS, 2018-2030 (USD MILLION)
TABLE 152. ARGENTINA CELL BANKING OUTSOURCING MARKET SIZE, BY MICROBIAL CELLS, 2018-2030 (USD MILLION)
TABLE 153. ARGENTINA CELL BANKING OUTSOURCING MARKET SIZE, BY STEM CELLS, 2018-2030 (USD MILLION)
TABLE 154. ARGENTINA CELL BANKING OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 155. ARGENTINA CELL BANKING OUTSOURCING MARKET SIZE, BY BIOPHARMACEUTICAL MANUFACTURING, 2018-2030 (USD MILLION)
TABLE 156. ARGENTINA CELL BANKING OUTSOURCING MARKET SIZE, BY GENE THERAPY, 2018-2030 (USD MILLION)
TABLE 157. ARGENTINA CELL BANKING OUTSOURCING MARKET SIZE, BY REGENERATIVE MEDICINE, 2018-2030 (USD MILLION)
TABLE 158. ARGENTINA CELL BANKING OUTSOURCING MARKET SIZE, BY VACCINE PRODUCTION, 2018-2030 (USD MILLION)
TABLE 159. ARGENTINA CELL BANKING OUTSOURCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 160. ARGENTINA CELL BANKING OUTSOURCING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 161. ARGENTINA CELL BANKING OUTSOURCING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 162. EUROPE, MIDDLE EAST & AFRICA CELL BANKING OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 163. EUROPE, MIDDLE EAST & AFRICA CELL BANKING OUTSOURCING MARKET SIZE, BY CELL EXPANSION SERVICES, 2018-2030 (USD MILLION)
TABLE 164. EUROPE, MIDDLE EAST & AFRICA CELL BANKING OUTSOURCING MARKET SIZE, BY LOGISTICS SERVICES, 2018-2030 (USD MILLION)
TABLE 165. EUROPE, MIDDLE EAST & AFRICA CELL BANKING OUTSOURCING MARKET SIZE, BY QUALITY CONTROL TESTING, 2018-2030 (USD MILLION)
TABLE 166. EUROPE, MIDDLE EAST & AFRICA CELL BANKING OUTSOURCING MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 167. EUROPE, MIDDLE EAST & AFRICA CELL BANKING OUTSOURCING MARKET SIZE, BY MAMMALIAN CELLS, 2018-2030 (USD MILLION)
TABLE 168. EUROPE, MIDDLE EAST & AFRICA CELL BANKING OUTSOURCING MARKET SIZE, BY MICROBIAL CELLS, 2018-2030 (USD MILLION)
TABLE 169. EUROPE, MIDDLE EAST & AFRICA CELL BANKING OUTSOURCING MARKET SIZE, BY STEM CELLS, 2018-2030 (USD MILLION)
TABLE 170. EUROPE, MIDDLE EAST & AFRICA CELL BANKING OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 171. EUROPE, MIDDLE EAST & AFRICA CELL BANKING OUTSOURCING MARKET SIZE, BY BIOPHARMACEUTICAL MANUFACTURING, 2018-2030 (USD MILLION)
TABLE 172. EUROPE, MIDDLE EAST & AFRICA CELL BANKING OUTSOURCING MARKET SIZE, BY GENE THERAPY, 2018-2030 (USD MILLION)
TABLE 173. EUROPE, MIDDLE EAST & AFRICA CELL BANKING OUTSOURCING MARKET SIZE, BY REGENERATIVE MEDICINE, 2018-2030 (USD MILLION)
TABLE 174. EUROPE, MIDDLE EAST & AFRICA CELL BANKING OUTSOURCING MARKET SIZE, BY VACCINE PRODUCTION, 2018-2030 (USD MILLION)
TABLE 175. EUROPE, MIDDLE EAST & AFRICA CELL BANKING OUTSOURCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 176. EUROPE, MIDDLE EAST & AFRICA CELL BANKING OUTSOURCING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 177. EUROPE, MIDDLE EAST & AFRICA CELL BANKING OUTSOURCING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 178. EUROPE, MIDDLE EAST & AFRICA CELL BANKING OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 179. UNITED KINGDOM CELL BANKING OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 180. UNITED KINGDOM CELL BANKING OUTSOURCING MARKET SIZE, BY CELL EXPANSION SERVICES, 2018-2030 (USD MILLION)
TABLE 181. UNITED KINGDOM CELL BANKING OUTSOURCING MARKET SIZE, BY LOGISTICS SERVICES, 2018-2030 (USD MILLION)
TABLE 182. UNITED KINGDOM CELL BANKING OUTSOURCING MARKET SIZE, BY QUALITY CONTROL TESTING, 2018-2030 (USD MILLION)
TABLE 183. UNITED KINGDOM CELL BANKING OUTSOURCING MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 184. UNITED KINGDOM CELL BANKING OUTSOURCING MARKET SIZE, BY MAMMALIAN CELLS, 2018-2030 (USD MILLION)
TABLE 185. UNITED KINGDOM CELL BANKING OUTSOURCING MARKET SIZE, BY MICROBIAL CELLS, 2018-2030 (USD MILLION)
TABLE 186. UNITED KINGDOM CELL BANKING OUTSOURCING MARKET SIZE, BY STEM CELLS, 2018-2030 (USD MILLION)
TABLE 187. UNITED KINGDOM CELL BANKING OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 188. UNITED KINGDOM CELL BANKING OUTSOURCING MARKET SIZE, BY BIOPHARMACEUTICAL MANUFACTURING, 2018-2030 (USD MILLION)
TABLE 189. UNITED KINGDOM CELL BANKING OUTSOURCING MARKET SIZE, BY GENE THERAPY, 2018-2030 (USD MILLION)
TABLE 190. UNITED KINGDOM CELL BANKING OUTSOURCING MARKET SIZE, BY REGENERATIVE MEDICINE, 2018-2030 (USD MILLION)
TABLE 191. UNITED KINGDOM CELL BANKING OUTSOURCING MARKET SIZE, BY VACCINE PRODUCTION, 2018-2030 (USD MILLION)
TABLE 192. UNITED KINGDOM CELL BANKING OUTSOURCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 193. UNITED KINGDOM CELL BANKING OUTSOURCING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 194. UNITED KINGDOM CELL BANKING OUTSOURCING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 195. GERMANY CELL BANKING OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 196. GERMANY CELL BANKING OUTSOURCING MARKET SIZE, BY CELL EXPANSION SERVICES, 2018-2030 (USD MILLION)
TABLE 197. GERMANY CELL BANKING OUTSOURCING MARKET SIZE, BY LOGISTICS SERVICES, 2018-2030 (USD MILLION)
TABLE 198. GERMANY CELL BANKING OUTSOURCING MARKET SIZE, BY QUALITY CONTROL TESTING, 2018-2030 (USD MILLION)
TABLE 199. GERMANY CELL BANKING OUTSOURCING MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 200. GERMANY CELL BANKING OUTSOURCING MARKET SIZE, BY MAMMALIAN CELLS, 2018-2030 (USD MILLION)
TABLE 201. GERMANY CELL BANKING OUTSOURCING MARKET SIZE, BY MICROBIAL CELLS, 2018-2030 (USD MILLION)
TABLE 202. GERMANY CELL BANKING OUTSOURCING MARKET SIZE, BY STEM CELLS, 2018-2030 (USD MILLION)
TABLE 203. GERMANY CELL BANKING OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 204. GERMANY CELL BANKING OUTSOURCING MARKET SIZE, BY BIOPHARMACEUTICAL MANUFACTURING, 2018-2030 (USD MILLION)
TABLE 205. GERMANY CELL BANKING OUTSOURCING MARKET SIZE, BY GENE THERAPY, 2018-2030 (USD MILLION)
TABLE 206. GERMANY CELL BANKING OUTSOURCING MARKET SIZE, BY REGENERATIVE MEDICINE, 2018-2030 (USD MILLION)
TABLE 207. GERMANY CELL BANKING OUTSOURCING MARKET SIZE, BY VACCINE PRODUCTION, 2018-2030 (USD MILLION)
TABLE 208. GERMANY CELL BANKING OUTSOURCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 209. GERMANY CELL BANKING OUTSOURCING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 210. GERMANY CELL BANKING OUTSOURCING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 211. FRANCE CELL BANKING OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 212. FRANCE CELL BANKING OUTSOURCING MARKET SIZE, BY CELL EXPANSION SERVICES, 2018-2030 (USD MILLION)
TABLE 213. FRANCE CELL BANKING OUTSOURCING MARKET SIZE, BY LOGISTICS SERVICES, 2018-2030 (USD MILLION)
TABLE 214. FRANCE CELL BANKING OUTSOURCING MARKET SIZE, BY QUALITY CONTROL TESTING, 2018-2030 (USD MILLION)
TABLE 215. FRANCE CELL BANKING OUTSOURCING MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 216. FRANCE CELL BANKING OUTSOURCING MARKET SIZE, BY MAMMALIAN CELLS, 2018-2030 (USD MILLION)
TABLE 217. FRANCE CELL BANKING OUTSOURCING MARKET SIZE, BY MICROBIAL CELLS, 2018-2030 (USD MILLION)
TABLE 218. FRANCE CELL BANKING OUTSOURCING MARKET SIZE, BY STEM CELLS, 2018-2030 (USD MILLION)
TABLE 219. FRANCE CELL BANKING OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 220. FRANCE CELL BANKING OUTSOURCING MARKET SIZE, BY BIOPHARMACEUTICAL MANUFACTURING, 2018-2030 (USD MILLION)
TABLE 221. FRANCE CELL BANKING OUTSOURCING MARKET SIZE, BY GENE THERAPY, 2018-2030 (USD MILLION)
TABLE 222. FRANCE CELL BANKING OUTSOURCING MARKET SIZE, BY REGENERATIVE MEDICINE, 2018-2030 (USD MILLION)
TABLE 223. FRANCE CELL BANKING OUTSOURCING MARKET SIZE, BY VACCINE PRODUCTION, 2018-2030 (USD MILLION)
TABLE 224. FRANCE CELL BANKING OUTSOURCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 225. FRANCE CELL BANKING OUTSOURCING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 226. FRANCE CELL BANKING OUTSOURCING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 227. RUSSIA CELL BANKING OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 228. RUSSIA CELL BANKING OUTSOURCING MARKET SIZE, BY CELL EXPANSION SERVICES, 2018-2030 (USD MILLION)
TABLE 229. RUSSIA CELL BANKING OUTSOURCING MARKET SIZE, BY LOGISTICS SERVICES, 2018-2030 (USD MILLION)
TABLE 230. RUSSIA CELL BANKING OUTSOURCING MARKET SIZE, BY QUALITY CONTROL TESTING, 2018-2030 (USD MILLION)
TABLE 231. RUSSIA CELL BANKING OUTSOURCING MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 232. RUSSIA CELL BANKING OUTSOURCING MARKET SIZE, BY MAMMALIAN CELLS, 2018-2030 (USD MILLION)
TABLE 233. RUSSIA CELL BANKING OUTSOURCING MARKET SIZE, BY MICROBIAL CELLS, 2018-2030 (USD MILLION)
TABLE 234. RUSSIA CELL BANKING OUTSOURCING MARKET SIZE, BY STEM CELLS, 2018-2030 (USD MILLION)
TABLE 235. RUSSIA CELL BANKING OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 236. RUSSIA CELL BANKING OUTSOURCING MARKET SIZE, BY BIOPHARMACEUTICAL MANUFACTURING, 2018-2030 (USD MILLION)
TABLE 237. RUSSIA CELL BANKING OUTSOURCING MARKET SIZE, BY GENE THERAPY, 2018-2030 (USD MILLION)
TABLE 238. RUSSIA CELL BANKING OUTSOURCING MARKET SIZE, BY REGENERATIVE MEDICINE, 2018-2030 (USD MILLION)
TABLE 239. RUSSIA CELL BANKING OUTSOURCING MARKET SIZE, BY VACCINE PRODUCTION, 2018-2030 (USD MILLION)
TABLE 240. RUSSIA CELL BANKING OUTSOURCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 241. RUSSIA CELL BANKING OUTSOURCING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 242. RUSSIA CELL BANKING OUTSOURCING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 243. ITALY CELL BANKING OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 244. ITALY CELL BANKING OUTSOURCING MARKET SIZE, BY CELL EXPANSION SERVICES, 2018-2030 (USD MILLION)
TABLE 245. ITALY CELL BANKING OUTSOURCING MARKET SIZE, BY LOGISTICS SERVICES, 2018-2030 (USD MILLION)
TABLE 246. ITALY CELL BANKING OUTSOURCING MARKET SIZE, BY QUALITY CONTROL TESTING, 2018-2030 (USD MILLION)
TABLE 247. ITALY CELL BANKING OUTSOURCING MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 248. ITALY CELL BANKING OUTSOURCING MARKET SIZE, BY MAMMALIAN CELLS, 2018-2030 (USD MILLION)
TABLE 249. ITALY CELL BANKING OUTSOURCING MARKET SIZE, BY MICROBIAL CELLS, 2018-2030 (USD MILLION)
TABLE 250. ITALY CELL BANKING OUTSOURCING MARKET SIZE, BY STEM CELLS, 2018-2030 (USD MILLION)
TABLE 251. ITALY CELL BANKING OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 252. ITALY CELL BANKING OUTSOURCING MARKET SIZE, BY BIOPHARMACEUTICAL MANUFACTURING, 2018-2030 (USD MILLION)
TABLE 253. ITALY CELL BANKING OUTSOURCING MARKET SIZE, BY GENE THERAPY, 2018-2030 (USD MILLION)
TABLE 254. ITALY CELL BANKING OUTSOURCING MARKET SIZE, BY REGENERATIVE MEDICINE, 2018-2030 (USD MILLION)
TABLE 255. ITALY CELL BANKING OUTSOURCING MARKET SIZE, BY VACCINE PRODUCTION, 2018-2030 (USD MILLION)
TABLE 256. ITALY CELL BANKING OUTSOURCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 257. ITALY CELL BANKING OUTSOURCING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 258. ITALY CELL BANKING OUTSOURCING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 259. SPAIN CELL BANKING OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 260. SPAIN CELL BANKING OUTSOURCING MARKET SIZE, BY CELL EXPANSION SERVICES, 2018-2030 (USD MILLION)
TABLE 261. SPAIN CELL BANKING OUTSOURCING MARKET SIZE, BY LOGISTICS SERVICES, 2018-2030 (USD MILLION)
TABLE 262. SPAIN CELL BANKING OUTSOURCING MARKET SIZE, BY QUALITY CONTROL TESTING, 2018-2030 (USD MILLION)
TABLE 263. SPAIN CELL BANKING OUTSOURCING MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 264. SPAIN CELL BANKING OUTSOURCING MARKET SIZE, BY MAMMALIAN CELLS, 2018-2030 (USD MILLION)
TABLE 265. SPAIN CELL BANKING OUTSOURCING MARKET SIZE, BY MICROBIAL CELLS, 2018-2030 (USD MILLION)
TABLE 266. SPAIN CELL BANKING OUTSOURCING MARKET SIZE, BY STEM CELLS, 2018-2030 (USD MILLION)
TABLE 267. SPAIN CELL BANKING OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 268. SPAIN CELL BANKING OUTSOURCING MARKET SIZE, BY BIOPHARMACEUTICAL MANUFACTURING, 2018-2030 (USD MILLION)
TABLE 269. SPAIN CELL BANKING OUTSOURCING MARKET SIZE, BY GENE THERAPY, 2018-2030 (USD MILLION)
TABLE 270. SPAIN CELL BANKING OUTSOURCING MARKET SIZE, BY REGENERATIVE MEDICINE, 2018-2030 (USD MILLION)
TABLE 271. SPAIN CELL BANKING OUTSOURCING MARKET SIZE, BY VACCINE PRODUCTION, 2018-2030 (USD MILLION)
TABLE 272. SPAIN CELL BANKING OUTSOURCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 273. SPAIN CELL BANKING OUTSOURCING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 274. SPAIN CELL BANKING OUTSOURCING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 275. UNITED ARAB EMIRATES CELL BANKING OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 276. UNITED ARAB EMIRATES CELL BANKING OUTSOURCING MARKET SIZE, BY CELL EXPANSION SERVICES, 2018-2030 (USD MILLION)
TABLE 277. UNITED ARAB EMIRATES CELL BANKING OUTSOURCING MARKET SIZE, BY LOGISTICS SERVICES, 2018-2030 (USD MILLION)
TABLE 278. UNITED ARAB EMIRATES CELL BANKING OUTSOURCING MARKET SIZE, BY QUALITY CONTROL TESTING, 2018-2030 (USD MILLION)
TABLE 279. UNITED ARAB EMIRATES CELL BANKING OUTSOURCING MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 280. UNITED ARAB EMIRATES CELL BANKING OUTSOURCING MARKET SIZE, BY MAMMALIAN CELLS, 2018-2030 (USD MILLION)
TABLE 281. UNITED ARAB EMIRATES CELL BANKING OUTSOURCING MARKET SIZE, BY MICROBIAL CELLS, 2018-2030 (USD MILLION)
TABLE 282. UNITED ARAB EMIRATES CELL BANKING OUTSOURCING MARKET SIZE, BY STEM CELLS, 2018-2030 (USD MILLION)
TABLE 283. UNITED ARAB EMIRATES CELL BANKING OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 284. UNITED ARAB EMIRATES CELL BANKING OUTSOURCING MARKET SIZE, BY BIOPHARMACEUTICAL MANUFACTURING, 2018-2030 (USD MILLION)
TABLE 285. UNITED ARAB EMIRATES CELL BANKING OUTSOURCING MARKET SIZE, BY GENE THERAPY, 2018-2030 (USD MILLION)
TABLE 286. UNITED ARAB EMIRATES CELL BANKING OUTSOURCING MARKET SIZE, BY REGENERATIVE MEDICINE, 2018-2030 (USD MILLION)
TABLE 287. UNITED ARAB EMIRATES CELL BANKING OUTSOURCING MARKET SIZE, BY VACCINE PRODUCTION, 2018-2030 (USD MILLION)
TABLE 288. UNITED ARAB EMIRATES CELL BANKING OUTSOURCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 289. UNITED ARAB EMIRATES CELL BANKING OUTSOURCING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 290. UNITED ARAB EMIRATES CELL BANKING OUTSOURCING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 291. SAUDI ARABIA CELL BANKING OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 292. SAUDI ARABIA CELL BANKING OUTSOURCING MARKET SIZE, BY CELL EXPANSION SERVICES, 2018-2030 (USD MILLION)
TABLE 293. SAUDI ARABIA CELL BANKING OUTSOURCING MARKET SIZE, BY LOGISTICS SERVICES, 2018-2030 (USD MILLION)
TABLE 294. SAUDI ARABIA CELL BANKING OUTSOURCING MARKET SIZE, BY QUALITY CONTROL TESTING, 2018-2030 (USD MILLION)
TABLE 295. SAUDI ARABIA CELL BANKING OUTSOURCING MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 296. SAUDI ARABIA CELL BANKING OUTSOURCING MARKET SIZE, BY MAMMALIAN CELLS, 2018-2030 (USD MILLION)
TABLE 297. SAUDI ARABIA CELL BANKING OUTSOURCING MARKET SIZE, BY MICROBIAL CELLS, 2018-2030 (USD MILLION)
TABLE 298. SAUDI ARABIA CELL BANKING OUTSOURCING MARKET SIZE, BY STEM CELLS, 2018-2030 (USD MILLION)
TABLE 299. SAUDI ARABIA CELL BANKING OUTSOURCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 300. SAUDI ARABIA CELL BANKING OUTSOURCING MARKET SIZE, BY BIOPHARMACEUTICAL MANUFACTURING, 2018-2030 (USD MILLION)
TABLE 301. SAUDI ARABIA CELL BANKING OUTSOURCING MARKET SIZE, BY GENE THERAPY, 2018-2030 (USD MILLION)
TABLE 302. SAUDI ARABIA CELL BANKING OUTSOURCING MARKET SIZE, BY REGENERATIVE MEDICINE, 2018-2030 (USD MILLION)
TABLE 303. SAUDI ARABIA CELL BANKING OUTSOURCING MARKET SIZE, BY VACCINE PRODUCTION, 2018-2030 (USD MILLION)
TABLE 304. SAUDI ARABIA CELL BANKING OUTSOURCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 305. SAUDI ARABIA CELL BANKING OUTSOURCING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 306. SAUDI ARABIA CELL BANKING OUTSOURCING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 307. SOUTH AFRICA CELL BANKING OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 308. SOUTH AFRICA CELL BANKING OUTSOURCING MARKET SIZE, BY CEL

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Cell Banking Outsourcing market report include:
  • Lonza Group AG
  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • Cytiva Uppsala AB
  • Fujifilm Diosynth Biotechnologies UK Limited
  • WuXi AppTec Co., Ltd.
  • AGC Biologics Inc.
  • Catalent, Inc.
  • Cobra Biologics Group Limited
  • Selexis SA

Table Information

Report AttributeDetails
No. of Pages199
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 16.96 Billion
Forecasted Market Value ( USD ) by 2030 $ 34.93 Billion
Compound Annual Growth Rate15.6%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Cell Banking Outsourcing - Global Strategic Business Report - Product Image

Cell Banking Outsourcing - Global Strategic Business Report

  • Report
  • 366 Pages
  • Global
From
Cell Banking Outsourcing Market Report 2025 - Product Image

Cell Banking Outsourcing Market Report 2025

  • Report
  • 200 Pages
  • Global
From
GMP Cell Banking Services - Global Strategic Business Report - Product Image

GMP Cell Banking Services - Global Strategic Business Report

  • Report
  • 194 Pages
  • Global
From
GMP Cell Banking Services Market by Cell Type, Product Type, Application, End User, Source, Scale, Storage Technology, Process Type, Distribution Channel - Global Forecast to 2030 - Product Image

GMP Cell Banking Services Market by Cell Type, Product Type, Application, End User, Source, Scale, Storage Technology, Process Type, Distribution Channel - Global Forecast to 2030

  • Report
  • 198 Pages
  • Global
From
Stem Cell Banking Market by Tissue Source, Cell Type, Application, Service Type, Ownership Model, End User - Global Forecast to 2030 - Product Image

Stem Cell Banking Market by Tissue Source, Cell Type, Application, Service Type, Ownership Model, End User - Global Forecast to 2030

  • Report
  • 186 Pages
  • Global
From

About the Cell Banking Outsourcing Market

Cell banking outsourcing is a service used in drug discovery to provide access to a variety of cell lines for use in research. It is a cost-effective way to obtain cell lines for use in drug development, as it eliminates the need to maintain and store cell lines in-house. Cell banking outsourcing also provides access to a wide range of cell lines, including those that are difficult to obtain or maintain in-house. This allows researchers to quickly access the cell lines they need for their research. Additionally, cell banking outsourcing can provide access to specialized cell lines, such as those used in stem cell research. Cell banking outsourcing is a growing market, with many companies offering services to researchers. These companies provide a range of services, including cell line acquisition, storage, and maintenance. They also offer services such as cell line authentication, cryopreservation, and cell line banking. Companies in this market include ATCC, Coriell Institute for Medical Research, and CellBank Australia. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.